查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1714626

按产品类型、应用和最终用户分類的生物资讯市场—2025-2030 年全球预测

Bioinformatics Market by Product Types, Applications, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计 2024 年生物资讯市场价值将达到 133.3 亿美元，2025 年成长至 150 亿美元，复合年增长率为 12.97%，到 2030 年将达到 277.2 亿美元。

介绍

主要市场统计数据
基准年2024年 133.3亿美元
预计2025年 150亿美元
预测年份 2030 277.2亿美元
复合年增长率（%） 12.97%

在当今快速发展的科技环境中，生物资讯学领域处于创新和颠覆的前沿。随着生物资料的数量和复杂性不断增加，该行业正在经历变革，再形成研究、诊断和药物开发的过程和结果。这项深入分析全面概况了推动生物资讯学未来发展的市场趋势、细分策略、关键区域和公司洞察。

本报告旨在探讨将彻底改变资料撷取、储存、分析和解释方式的新技术和创新工具。透过仔细研究最近的趋势和市场动态，读者将踏上一段旅程，了解解决复杂生物问题的科学努力如何变得更加全面、精简和有针对性。本报告说明深入分析和高层次观点，帮助产业专业人士和策略决策者理解复杂的生物资讯学格局。

本报告的目的是为了解影响市场的关键驱动因素奠定基础，并深入了解生物资讯学平台、服务和工具的持续发展。在数位转型和资料主导决策对科学进步和医疗保健改善至关重要的时代，这种见解尤其重要。读者将会欣赏这项研究背后严谨的方法、明确的发现以及与学术和企业抱负产生共鸣的实际意义。

改变生物资讯市场

生物资讯学领域正在经历一系列变革时期，重新定义研究和发展的发展方式。运算能力、人工智慧和资料分析的突破性进展不仅提高了生物资料处理的速度和准确性，而且还带来了整合不同资料集的新方法。云端处理、机器学习和高通量测序等重大技术创新正在为前所未有的资料整合和解释水平奠定基础。

最显着的变化之一是不同资料源的整合，从基因组学到蛋白质组学到代谢体学。这种整合可以实现复杂的模式识别和预测分析，为药物发现和临床诊断提供更有效的途径。此外，传统生物分析方法与现代计算技术的结合产生了将手动专业知识与自动化流程相结合的混合系统，从而改善了研究成果。

生物资讯学的数位转型正在促进更灵活、反应更快的研究环境。资料视觉化工具和即时监控系统的兴起使得研究人员能够以以前无法实现的速度处理大型资料集并获得可行的见解。因此，市场非常重视互通性，其係统旨在实现无缝通讯并支援跨全球网路的协作计划。

此外，知识管理的进步对于将复杂的资料集提炼为有意义的情报至关重要。这些变革性转变不仅代表着技术升级；它们代表了生物学研究概念化和实施方式上的根本性变化。随着技术创新不断加速，市场相关人员被迫快速适应以保持竞争力，促使对下一代工具和方法的进一步投资。

关键细分洞察

細項分析提供了对生物资讯市场的细緻观察，重点关注产品类型、应用和最终用户类别。产品细分涵盖生物资讯平台、生物资讯服务和知识管理工具。深入挖掘，生物资讯平台进一步使用序列比对平台，序列分析平台，序列操作平台和结构功能分析平台等子区隔进行分析。同样，与生物资讯服务相关的部分分为资料分析、资料库管理和定序等领域，每个领域在塑造市场表现和客户参与方面都发挥着自己的作用。

基于应用的细分突出了农业生物技术、临床诊断、药物发现和开发、基因组学以及蛋白质组学和代谢体学等领域的多样化使用场景。例如，农业生物技术领域从两个角度进行研究：基因改造生物开发和植物育种工具。在药物发现和开发领域，分析药物筛检和标靶识别等重要方面以揭示潜在的新治疗方法。基因组学领域本身已分为两大阵营：比较基因组学和功能基因组学，凸显了业界为加强基因分析的比较和应用所做的努力。

根据最终用户进一步细分显示，该市场迎合学术和研究机构、农业和环境部门、医疗保健提供者以及製药和生物技术公司。在学术和研究方面，该分析考虑了研究机构和大学在推动创新和促进教育卓越方面发挥的关键作用。在医疗保健领域，诊断中心和医院之间存在区别，每个中心都有不同的要求和挑战。这些细分洞察有助于了解不同的客户需求，并在日益动态的市场环境中发现有针对性的解决方案的机会。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 提高对生物技术和基因工程应用的认识和接受度
      • 增加政府对基因组研究和生物资讯工具的资助和投入
      • 基因组学在个人化医疗和精准医疗的应用日益广泛
    • 限制因素
      • 处理敏感遗传资讯的隐私问题
    • 机会
      • 开发大麻基因组学平台以改善品种选择和治疗应用
      • 拓展生物资讯学在精准医疗的应用，增强个人化治疗策略
    • 任务
      • 管理和分析大型资料的复杂性阻碍了研究进展
  • 市场区隔分析
    • 产品类型：越来越多地采用生物资讯学平台来获取有意义的生物学见解
    • 最终用户：医疗保健提供者越来越多地使用生物资讯学进行个人化医疗和疾病诊断
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社会
    • 技术的
    • 合法的
    • 环境

第六章 生物资讯市场（依产品类型）

  • 生物资讯平台
    • 序列比对平台
    • 序列分析平台
    • 序列操作平台
    • 结构与功能分析平台
  • 生物资讯服务
    • 资料分析
    • 资料库管理
    • 定序
  • 知识管理工具

第七章生物资讯市场（按应用）

  • 农业生物技术
    • 基因改造生物的发展
    • 植物育种工具
  • 临床诊断
  • 药物研发
    • 药物检测
    • 目标识别
  • 基因组学
    • 比较基因组学
    • 功能基因体学
  • 蛋白质体学和代谢体学

第 8 章 生物资讯市场（按最终用户）

  • 学术研究所
    • 研究部门
    • 大学
  • 农业和环境部门
  • 医疗保健提供者
    • 诊断中心
    • 医院
  • 製药和生物技术公司

第九章美洲生物资讯学市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太生物资讯学市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第 11 章欧洲、中东和非洲生物资讯市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争情境分析
  • 战略分析与建议

公司名单

  • 10x Genomics, Inc.
  • Agilent Technologies, Inc.
  • BGI Group
  • Bio-Rad Laboratories, Inc.
  • BioDiscovery Group
  • biomodal Limited
  • Dassault Systemes SE
  • DNASTAR, Inc.
  • Eurofins Genomics LLC
  • F. Hoffmann-La Roche Ltd
  • Genevia Technologies Oy
  • Genomics Ltd.
  • HaploX
  • Illumina, Inc.
  • Integrated DNA Technologies, Inc.
  • Labcorp Genetics Inc.
  • Labvantage-Biomax GmbH
  • Novo Nordisk A/S
  • Oxford Nanopore Technologies plc.
  • Pacific Biosciences of California, Inc.
  • Partek Incorporated
  • PerkinElmer, Inc.
  • Qiagen NV
  • RIKEN GENESIS CO.,LTD.
  • SOPHiA GENETICS SA
  • Telesis Bio Inc.
  • Thermo Fisher Scientific Inc.
  • Veracyte, Inc.
  • Waters Corporation
Product Code: MRR-434CCDA04CC1

The Bioinformatics Market was valued at USD 13.33 billion in 2024 and is projected to grow to USD 15.00 billion in 2025, with a CAGR of 12.97%, reaching USD 27.72 billion by 2030.

Introduction

KEY MARKET STATISTICS
Base Year [2024] USD 13.33 billion
Estimated Year [2025] USD 15.00 billion
Forecast Year [2030] USD 27.72 billion
CAGR (%) 12.97%

In today's rapidly evolving scientific and technological environment, the bioinformatics sector is at the forefront of innovation and disruption. With the growing volume and complexity of biological data, the industry is experiencing transformative changes that are reshaping processes and outcomes across research, diagnostics, and drug development. This in-depth analysis provides a comprehensive overview of market trends, segmentation strategies, and key regional and company insights that are driving the future of bioinformatics.

This report embarks on an exploration of emerging technologies and innovative tools that are revolutionizing data acquisition, storage, analysis, and interpretation. Through a careful examination of recent developments and market dynamics, readers are taken on a journey that highlights how scientific endeavors are becoming more integrated, efficient, and targeted in addressing complex biological questions. The discussion that follows offers a blend of detailed analytics and high-level perspectives, thereby serving both industry experts and strategic decision-makers who seek to understand the intricacies of the modern bioinformatics landscape.

The purpose of this report is to create a foundation of understanding regarding the critical drivers influencing the market and to provide insights into the evolving nature of bioinformatics platforms, services, and tools. Such insights are especially important in an era where digital transformation and data-driven decision-making have become central to scientific advancement and healthcare improvements. Readers will appreciate the rigorous methodology behind the research, the clarity of the findings, and the actionable implications that resonate with both academic and corporate ambitions.

Transformative Shifts in the Landscape

The bioinformatics landscape is undergoing a series of transformative shifts that are redefining how research and development are conducted. Groundbreaking advancements in computational power, artificial intelligence, and data analytics have not only improved the speed and accuracy of biological data processing but have also ushered in new methodologies for integrating diverse data sets. Key technological innovations such as cloud computing, machine learning, and high-throughput sequencing are laying the groundwork for unprecedented levels of data integration and interpretation.

One of the most notable shifts is the consolidation of various data sources - from genomics to proteomics and metabolomics. This convergence has enabled complex pattern recognition and predictive analytics, resulting in more efficient pathways for drug discovery and clinical diagnostics. Moreover, the integration of traditional bioanalytical methods with modern computational techniques is giving rise to hybrid systems that combine manual expertise with automated processes, leading to enhanced research outcomes.

Digital transformation in bioinformatics is facilitating a more agile and responsive research environment. With the rise of data visualization tools and real-time monitoring systems, researchers are now better equipped to handle large-scale datasets and draw actionable insights at a speed that was previously unattainable. Consequently, the market has seen a growing emphasis on interoperability, where systems are designed to communicate seamlessly and support collaborative projects across global networks.

Additionally, advancements in knowledge management are proving critical in distilling complex datasets into meaningful intelligence. These transformative shifts are not simply technological upgrades; they represent a fundamental change in the way biological research is conceptualized and executed. As innovation continues to accelerate, market players are compelled to adapt quickly to maintain competitive advantages, driving further investments in next-generation tools and methodologies.

Key Segmentation Insights

The segmentation analysis offers a nuanced view of the bioinformatics market by focusing on product types, applications, and end-user categories. In terms of product segmentation, the market is studied across bioinformatics platforms, bioinformatics services, and knowledge management tools. Delving deeper, the bioinformatics platforms are further analyzed using sub-segments such as sequence alignment platforms, sequence analysis platforms, sequence manipulation platforms, and structural as well as functional analysis platforms. Similarly, the segment pertaining to bioinformatics services is broken down into areas including data analysis, database management, and sequencing, each of which plays a unique role in shaping market performance and customer engagement.

The application-based segmentation highlights the diverse usage scenarios which span areas like agricultural biotechnology, clinical diagnostics, drug discovery and development, genomics, and proteomics and metabolomics. For instance, the agricultural biotechnology segment is explored through the twin lenses of genetically modified organisms development and plant breeding tools. In the realm of drug discovery and development, crucial aspects such as drug screening and target identification are analyzed to capture the robust potential of emerging therapies. The genomics segment itself is bifurcated into comparative genomics and functional genomics, underscoring how the industry is striving to enhance both the comparative and applied aspects of genetic analysis.

Further segmentation based on end-user reveals that the market caters to academic and research institutes, agricultural and environmental sectors, healthcare providers, and pharmaceutical as well as biotechnology companies. In academic and research institutes, the analysis takes into account the roles of both research laboratories and universities, which are pivotal in driving innovation and fostering educational excellence. On the healthcare front, differentiation is made between diagnostic centers and hospitals, as each setting has distinct requirements and challenges. Collectively, these segmentation insights help in understanding the varied customer demands and uncovering opportunities for targeted solutions in an increasingly dynamic market environment.

Based on Product Types, market is studied across Bioinformatics Platforms, Bioinformatics Services, and Knowledge Management Tools. The Bioinformatics Platforms is further studied across Sequence Alignment Platforms, Sequence Analysis Platforms, Sequence Manipulation Platforms, and Structural & Functional Analysis Platforms. The Bioinformatics Services is further studied across Data Analysis, Database Management, and Sequencing.

Based on Applications, market is studied across Agricultural Biotechnology, Clinical Diagnostics, Drug Discovery & Development, Genomics, and Proteomics & Metabolomics. The Agricultural Biotechnology is further studied across GMOs Development and Plant Breeding Tools. The Drug Discovery & Development is further studied across Drug Screening and Target Identification. The Genomics is further studied across Comparative Genomics and Functional Genomics.

Based on End-User, market is studied across Academic & Research Institutes, Agricultural & Environmental Sectors, Healthcare Providers, and Pharmaceutical & Biotechnology Companies. The Academic & Research Institutes is further studied across Research Labs and Universities. The Healthcare Providers is further studied across Diagnostic Centers and Hospitals.

Key Regional Insights

A comprehensive regional analysis reveals that the bioinformatics market is segmented into distinct geographical landscapes, each with its own set of unique opportunities and challenges. In the Americas, market growth is propelled by robust investments in healthcare infrastructure and research innovation. The dynamic nature of the regulatory framework, combined with a strong foundation in academic research and biotechnology, is fostering an environment where advanced bioinformatics tools can thrive. Economic policies and funding initiatives have further reinforced the region's status as a hub for technological advancements and high-end bioinformatics solutions.

When examining the Europe, Middle East & Africa region, a blend of mature market dynamics and emerging technological trends is apparent. European countries, known for their rigorous research standards and integrated healthcare systems, are at the forefront of adopting innovative bioinformatics platforms. Simultaneously, the Middle East and Africa are gradually enhancing their infrastructural capabilities, thereby creating significant opportunities for investments in bioinformatics. This mix of mature and nascent markets calls for tailored strategies that balance advanced technology adoption with the need for infrastructural development and local capacity building.

In the Asia-Pacific, rapid urbanization paired with increasing investments in scientific research is reshaping the bioinformatics landscape. The area is witnessing accelerated adoption of advanced sequencing technologies, cloud-based analytics, and automated solutions, which have a profound impact on both clinical diagnostics and agricultural biotechnology. This region's focus on innovation is further boosted by government initiatives and private sector investments, ensuring that bioinformatics remains a pivotal element of the overall digital transformation strategy. The contrasting market maturity levels across these regions highlight the diverse challenges and opportunities present in a globally interconnected marketplace.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Insights

The bioinformatics market is characterized by the presence of several prominent players that are instrumental in driving industry evolution and setting new standards in innovation. Leading companies, including 10x Genomics, Inc., Agilent Technologies, Inc., and BGI Group, have been at the forefront of technological advancements, continually offering cutting-edge platforms and services that address the complex needs of modern biological research. Further reinforcing market dynamics, Bio-Rad Laboratories, Inc. and BioDiscovery Group have mastered the integration of analytical tools with high-throughput processing capabilities, thereby influencing both clinical and research applications.

Other significant contributors such as biomodal Limited and Dassault Systemes S.E. have expanded their footprints by developing innovative software solutions that enhance data visualization and management across multiple bioinformatics applications. Companies like DNASTAR, Inc. and Eurofins Genomics LLC focus on providing specialized analytical services that cater to the growing demand for precise and reproducible results in genetic research and clinical diagnostics. Industry leaders like F. Hoffmann-La Roche Ltd. and Genevia Technologies Oy are well-regarded for their robust research and development capabilities, which in turn drive greater efficiency and accuracy in data analysis protocols.

The landscape further benefits from the presence of emerging innovators such as Genomics Ltd., HaploX, and Illumina, Inc., each of which brings a unique perspective by harnessing the power of next-generation sequencing and other advanced analytical techniques. Integrated DNA Technologies, Inc. and Labcorp Genetics Inc. continue to refine sequencing services, ensuring that both the scale and scope of data processing are aligned with evolving research demands. Additionally, contributions from Labvantage - Biomax GmbH, Novo Nordisk A/S, and Oxford Nanopore Technologies plc. have created pathways for enhancing the overall efficiency of bioinformatics applications.

The market is further enriched by the participation of Pacific Biosciences of California, Inc., Partek Incorporated, PerkinElmer, Inc., Qiagen N.V., RIKEN GENESIS CO.,LTD., SOPHiA GENETICS SA, Telesis Bio Inc., Thermo Fisher Scientific Inc., Veracyte, Inc., and Waters Corporation. These companies, through their relentless pursuit of innovation and excellence, continue to raise the bar for product development, service excellence, and technological integration, thereby underpinning a competitive and forward-looking market environment.

The report delves into recent significant developments in the Bioinformatics Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., Agilent Technologies, Inc., BGI Group, Bio-Rad Laboratories, Inc., BioDiscovery Group, biomodal Limited, Dassault Systemes S.E., DNASTAR, Inc., Eurofins Genomics LLC, F. Hoffmann-La Roche Ltd, Genevia Technologies Oy, Genomics Ltd., HaploX, Illumina, Inc., Integrated DNA Technologies, Inc., Labcorp Genetics Inc., Labvantage - Biomax GmbH, Novo Nordisk A/S, Oxford Nanopore Technologies plc., Pacific Biosciences of California, Inc., Partek Incorporated, PerkinElmer, Inc., Qiagen N.V., RIKEN GENESIS CO.,LTD., SOPHiA GENETICS SA, Telesis Bio Inc., Thermo Fisher Scientific Inc., Veracyte, Inc., and Waters Corporation. Actionable Recommendations for Industry Leaders

For decision-makers and market strategists, the key to leveraging competitive advantage in the bioinformatics sector lies in fostering innovation, optimizing technological integration, and aligning offerings with evolving customer needs. Leaders are advised to invest in research and development, particularly in areas that integrate advanced data analytics with automated sequencing and structural analysis. It is essential to focus on developing hybrid systems that blend traditional methodologies with modern computational capabilities. This approach not only improves accuracy but also enhances the speed at which complex biological datasets are interpreted.

Building strategic alliances with technology innovators and research institutions can accelerate the adoption of new platforms. Industry players should seek partnerships that enable access to state-of-the-art tools and facilitate knowledge sharing across various scientific domains. In parallel, efforts should be made to streamline regulatory compliance and ensure that data security measures are robust, given the sensitivity of biological and patient data.

Another focal point is the exploration of untapped regional markets. As emerging economies invest heavily in infrastructure and digital transformation, expanding into these regions can offer substantial growth opportunities. Tailoring strategies that address localized needs while leveraging global expertise can provide a sustainable competitive edge. Additionally, diversifying product portfolios to include both hardware and software solutions in bioinformatics will cater to the increasingly sophisticated demands of end-users and help capture a broader market share.

Future-proofing investment decisions remains critical. Leaders must continuously monitor technological advances and market trends to preempt disruptive changes. Embracing a culture of agility-where products and services can be rapidly adapted to changing scenarios-will be vital in maintaining relevance. In summary, actionable recommendations focus on enhancing innovation pipelines, forging strategic collaborations, expanding into new geographical territories, and adopting flexible business models that can withstand the dynamic nature of the bioinformatics landscape.

Conclusion

In conclusion, the bioinformatics market is presently experiencing a period of dynamic transformation driven by rapid technological advancements and integrated data analysis methods. Through a detailed examination of market segmentation, regional influences, and key players, the current landscape emerges as both highly complex and filled with opportunity. The sector's evolution is propelled by a confluence of advanced computational tools, innovative product offerings, and a deepening understanding of biological complexities.

The insights provided in this report underscore the importance of a multi-faceted approach to market strategy, one that seamlessly blends technological innovation with clear, actionable business strategies. By embracing digital transformation and leveraging state-of-the-art analytical methods, industry stakeholders have the opportunity to drive significant breakthroughs in research and healthcare delivery. Moreover, the comprehensive analysis of segmentation and regional trends paves the way for more targeted investments and enhanced market positioning.

Ultimately, as the bioinformatics market continues to expand and mature, the integration of diverse technological advancements with robust analytical frameworks will determine the future trajectory of the industry. Stakeholders who remain agile and forward-thinking are well poised to capitalize on emerging trends and contribute to the evolution of this critical field.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing awareness and acceptance of biotechnology and genetic engineering applications
      • 5.1.1.2. Increasing government funding and initiatives for genomic research and bioinformatics tools
      • 5.1.1.3. Growing adoption of personalized medicine and precision healthcare applications in genomics
    • 5.1.2. Restraints
      • 5.1.2.1. Privacy concerns associated with the handling of sensitive genetic information
    • 5.1.3. Opportunities
      • 5.1.3.1. Developing bioinformatics platforms for cannabis genomics to improve strain selection and therapeutic use
      • 5.1.3.2. Expanding the application of bioinformatics in precision medicine to enhance personalized treatment strategies
    • 5.1.4. Challenges
      • 5.1.4.1. Complexity in managing and analyzing large-scale datasets hinders research progress
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Types: Growing adoption of bioinformatics platforms to derive meaningful biological insights
    • 5.2.2. End-User: Rising utilization of bioinformatics in healthcare providers for personalized medicine and disease diagnosis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Bioinformatics Market, by Product Types

  • 6.1. Introduction
  • 6.2. Bioinformatics Platforms
    • 6.2.1. Sequence Alignment Platforms
    • 6.2.2. Sequence Analysis Platforms
    • 6.2.3. Sequence Manipulation Platforms
    • 6.2.4. Structural & Functional Analysis Platforms
  • 6.3. Bioinformatics Services
    • 6.3.1. Data Analysis
    • 6.3.2. Database Management
    • 6.3.3. Sequencing
  • 6.4. Knowledge Management Tools

7. Bioinformatics Market, by Applications

  • 7.1. Introduction
  • 7.2. Agricultural Biotechnology
    • 7.2.1. GMOs Development
    • 7.2.2. Plant Breeding Tools
  • 7.3. Clinical Diagnostics
  • 7.4. Drug Discovery & Development
    • 7.4.1. Drug Screening
    • 7.4.2. Target Identification
  • 7.5. Genomics
    • 7.5.1. Comparative Genomics
    • 7.5.2. Functional Genomics
  • 7.6. Proteomics & Metabolomics

8. Bioinformatics Market, by End-User

  • 8.1. Introduction
  • 8.2. Academic & Research Institutes
    • 8.2.1. Research Labs
    • 8.2.2. Universities
  • 8.3. Agricultural & Environmental Sectors
  • 8.4. Healthcare Providers
    • 8.4.1. Diagnostic Centers
    • 8.4.2. Hospitals
  • 8.5. Pharmaceutical & Biotechnology Companies

9. Americas Bioinformatics Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Bioinformatics Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Bioinformatics Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2024
  • 12.2. FPNV Positioning Matrix, 2024
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Solis Agrosciences enhances bioinformatics capabilities with acquisition of Ferris Genomics platform to boost agriculture innovation
    • 12.3.2. Seqera unveils AWS-backed containers to streamline bioinformatics research and foster innovation
    • 12.3.3. Metabolon launches advanced bioinformatics platform enhancing precision in metabolomics research
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 10x Genomics, Inc.
  • 2. Agilent Technologies, Inc.
  • 3. BGI Group
  • 4. Bio-Rad Laboratories, Inc.
  • 5. BioDiscovery Group
  • 6. biomodal Limited
  • 7. Dassault Systemes S.E.
  • 8. DNASTAR, Inc.
  • 9. Eurofins Genomics LLC
  • 10. F. Hoffmann-La Roche Ltd
  • 11. Genevia Technologies Oy
  • 12. Genomics Ltd.
  • 13. HaploX
  • 14. Illumina, Inc.
  • 15. Integrated DNA Technologies, Inc.
  • 16. Labcorp Genetics Inc.
  • 17. Labvantage - Biomax GmbH
  • 18. Novo Nordisk A/S
  • 19. Oxford Nanopore Technologies plc.
  • 20. Pacific Biosciences of California, Inc.
  • 21. Partek Incorporated
  • 22. PerkinElmer, Inc.
  • 23. Qiagen N.V.
  • 24. RIKEN GENESIS CO.,LTD.
  • 25. SOPHiA GENETICS SA
  • 26. Telesis Bio Inc.
  • 27. Thermo Fisher Scientific Inc.
  • 28. Veracyte, Inc.
  • 29. Waters Corporation

LIST OF FIGURES

  • FIGURE 1. BIOINFORMATICS MARKET MULTI-CURRENCY
  • FIGURE 2. BIOINFORMATICS MARKET MULTI-LANGUAGE
  • FIGURE 3. BIOINFORMATICS MARKET RESEARCH PROCESS
  • FIGURE 4. BIOINFORMATICS MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL BIOINFORMATICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOINFORMATICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL BIOINFORMATICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BIOINFORMATICS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL BIOINFORMATICS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS BIOINFORMATICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 15. AMERICAS BIOINFORMATICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES BIOINFORMATICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 17. UNITED STATES BIOINFORMATICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOINFORMATICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BIOINFORMATICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. BIOINFORMATICS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 23. BIOINFORMATICS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BIOINFORMATICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BIOINFORMATICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOINFORMATICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOINFORMATICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOINFORMATICS MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOINFORMATICS MARKET SIZE, BY SEQUENCE ALIGNMENT PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOINFORMATICS MARKET SIZE, BY SEQUENCE ANALYSIS PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOINFORMATICS MARKET SIZE, BY SEQUENCE MANIPULATION PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOINFORMATICS MARKET SIZE, BY STRUCTURAL & FUNCTIONAL ANALYSIS PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOINFORMATICS MARKET SIZE, BY DATA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOINFORMATICS MARKET SIZE, BY DATABASE MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOINFORMATICS MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOINFORMATICS MARKET SIZE, BY KNOWLEDGE MANAGEMENT TOOLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BIOINFORMATICS MARKET SIZE, BY GMOS DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BIOINFORMATICS MARKET SIZE, BY PLANT BREEDING TOOLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BIOINFORMATICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL BIOINFORMATICS MARKET SIZE, BY DRUG SCREENING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL BIOINFORMATICS MARKET SIZE, BY TARGET IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL BIOINFORMATICS MARKET SIZE, BY GENOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL BIOINFORMATICS MARKET SIZE, BY COMPARATIVE GENOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL BIOINFORMATICS MARKET SIZE, BY FUNCTIONAL GENOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL BIOINFORMATICS MARKET SIZE, BY PROTEOMICS & METABOLOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL BIOINFORMATICS MARKET SIZE, BY RESEARCH LABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL BIOINFORMATICS MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL & ENVIRONMENTAL SECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL BIOINFORMATICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL BIOINFORMATICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL BIOINFORMATICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS BIOINFORMATICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 61. ARGENTINA BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. ARGENTINA BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 63. ARGENTINA BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 64. ARGENTINA BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. ARGENTINA BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 66. ARGENTINA BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 70. BRAZIL BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 71. BRAZIL BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. BRAZIL BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 73. BRAZIL BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 74. BRAZIL BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. BRAZIL BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 76. BRAZIL BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 77. CANADA BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 78. CANADA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 79. CANADA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 80. CANADA BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 81. CANADA BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. CANADA BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 83. CANADA BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 84. CANADA BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. CANADA BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 86. CANADA BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 87. MEXICO BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 88. MEXICO BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 89. MEXICO BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 90. MEXICO BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 91. MEXICO BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. MEXICO BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 93. MEXICO BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 94. MEXICO BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. MEXICO BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 96. MEXICO BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED STATES BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED STATES BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED STATES BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED STATES BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED STATES BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED STATES BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED STATES BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED STATES BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. UNITED STATES BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 106. UNITED STATES BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 107. UNITED STATES BIOINFORMATICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 119. AUSTRALIA BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 120. AUSTRALIA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 121. AUSTRALIA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 122. AUSTRALIA BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 123. AUSTRALIA BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 124. AUSTRALIA BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 125. AUSTRALIA BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 126. AUSTRALIA BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. AUSTRALIA BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 128. AUSTRALIA BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 129. CHINA BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 130. CHINA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 131. CHINA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 132. CHINA BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 133. CHINA BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. CHINA BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 135. CHINA BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 136. CHINA BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. CHINA BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 138. CHINA BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 139. INDIA BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 140. INDIA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 141. INDIA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 142. INDIA BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 143. INDIA BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 144. INDIA BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 145. INDIA BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 146. INDIA BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. INDIA BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 148. INDIA BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 149. INDONESIA BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 150. INDONESIA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 151. INDONESIA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 152. INDONESIA BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 153. INDONESIA BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 154. INDONESIA BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 155. INDONESIA BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 156. INDONESIA BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. INDONESIA BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 158. INDONESIA BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 159. JAPAN BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 160. JAPAN BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 161. JAPAN BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 162. JAPAN BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 163. JAPAN BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 164. JAPAN BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 165. JAPAN BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 166. JAPAN BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. JAPAN BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 168. JAPAN BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 169. MALAYSIA BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 170. MALAYSIA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 171. MALAYSIA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 172. MALAYSIA BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 173. MALAYSIA BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 174. MALAYSIA BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 175. MALAYSIA BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 176. MALAYSIA BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. MALAYSIA BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 178. MALAYSIA BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 179. PHILIPPINES BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 180. PHILIPPINES BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 181. PHILIPPINES BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 182. PHILIPPINES BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 183. PHILIPPINES BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 184. PHILIPPINES BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 185. PHILIPPINES BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 186. PHILIPPINES BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. PHILIPPINES BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 188. PHILIPPINES BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 189. SINGAPORE BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 190. SINGAPORE BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 191. SINGAPORE BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 192. SINGAPORE BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 193. SINGAPORE BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 194. SINGAPORE BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 195. SINGAPORE BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 196. SINGAPORE BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. SINGAPORE BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 198. SINGAPORE BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH KOREA BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH KOREA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH KOREA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH KOREA BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH KOREA BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH KOREA BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH KOREA BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH KOREA BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH KOREA BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 208. SOUTH KOREA BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 209. TAIWAN BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 210. TAIWAN BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 211. TAIWAN BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 212. TAIWAN BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 213. TAIWAN BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 214. TAIWAN BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 215. TAIWAN BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 216. TAIWAN BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 217. TAIWAN BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 218. TAIWAN BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 219. THAILAND BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 220. THAILAND BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 221. THAILAND BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 222. THAILAND BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 223. THAILAND BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 224. THAILAND BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 225. THAILAND BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 226. THAILAND BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 227. THAILAND BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 228. THAILAND BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 229. VIETNAM BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 230. VIETNAM BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 231. VIETNAM BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 232. VIETNAM BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 233. VIETNAM BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 234. VIETNAM BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 235. VIETNAM BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 236. VIETNAM BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 237. VIETNAM BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 238. VIETNAM BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA BIOINFORMATICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 250. DENMARK BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 251. DENMARK BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 252. DENMARK BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 253. DENMARK BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 254. DENMARK BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 255. DENMARK BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 256. DENMARK BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 257. DENMARK BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 258. DENMARK BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 259. DENMARK BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 260. EGYPT BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 261. EGYPT BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 262. EGYPT BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 263. EGYPT BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 264. EGYPT BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 265. EGYPT BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 266. EGYPT BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 267. EGYPT BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 268. EGYPT BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 269. EGYPT BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 270. FINLAND BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 271. FINLAND BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 272. FINLAND BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 273. FINLAND BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 274. FINLAND BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 275. FINLAND BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 276. FINLAND BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 277. FINLAND BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 278. FINLAND BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 279. FINLAND BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 280. FRANCE BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 281. FRANCE BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 282. FRANCE BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 283. FRANCE BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 284. FRANCE BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 285. FRANCE BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 286. FRANCE BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 287. FRANCE BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 288. FRANCE BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 289. FRANCE BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 290. GERMANY BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 291. GERMANY BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 292. GERMANY BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 293. GERMANY BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 294. GERMANY BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 295. GERMANY BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 296. GERMANY BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 297. GERMANY BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 298. GERMANY BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 299. GERMANY BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 300. ISRAEL BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 301. ISRAEL BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 302. ISRAEL BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 303. ISRAEL BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 304. ISRAEL BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 305. ISRAEL BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 306. ISRAEL BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 307. ISRAEL BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 308. ISRAEL BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 309. ISRAEL BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 310. ITALY BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 311. ITALY BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 312. ITALY BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 313. ITALY BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 314. ITALY BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 315. ITALY BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 316. ITALY BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 317. ITALY BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 318. ITALY BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 319. ITALY BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 320. NETHERLANDS BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 321. NETHERLANDS BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 322. NETHERLANDS BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 323. NETHERLANDS BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 324. NETHERLANDS BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 325. NETHERLANDS BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 326. NETHERLANDS BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 327. NETHERLANDS BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 328. NETHERLANDS BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 329. NETHERLANDS BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 330. NIGERIA BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 331. NIGERIA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 332. NIGERIA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 333. NIGERIA BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 334. NIGERIA BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 335. NIGERIA BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 336. NIGERIA BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 337. NIGERIA BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 338. NIGERIA BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 339. NIGERIA BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 340. NORWAY BIOINFORMATICS MARKET SIZE, BY